US Pharma MarketingAll 50 states sign up for most favored nation prices under Medicaid, Trump says
All 50 states, DC and Puerto Rico join CMS Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation…
President Donald Trump on Friday announced that all 50 states, Washington, DC, and Puerto Rico will participate in a new drug pricing model under which pharma companies will provide supplemental rebates to align Medicaid net ...
Source: Endpoints News